The DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.
OPC-21268, an Orally Effective, Nonpeptide Vasopressin V1 Receptor Antagonist
Abstract
An orally effective, nonpeptide, vasopressin V1 receptor antagonist, OPC-21268, has been identified. This compound selectively antagonized binding to the V1 subtype of the vasopressin receptor in a competitive manner. In vivo, the compound acted as a specific antagonist of arginine vasopressin (AVP)-induced vasoconstriction. After oral administration in conscious rats, the compound also antagonized pressor responses to AVP. OPC-21268 can be used to study the physiological role of AVP and may be therapeutically useful in the treatment of hypertension and congestive heart failure.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
PROTEIN MEASUREMENT WITH THE FOLIN PHENOL REAGENT
Lowry, O., Rosebrough, N., Farr, A. L., & Randall, R. (1951) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)52451-6 · Cited by 317,331
Inositol Trisphosphate, a Novel Second Messenger in Cellular Signal Transduction
Berridge, M. J., & Irvine, R. F. (1984) · Nature · doi:10.1038/312315a0 · Cited by 6,086
Kruszynski, M., Lammek, B., Manning, M., Seto, J., Haldar, J., & Sawyer, W. H. (1980) · Journal of Medicinal Chemistry · doi:10.1021/jm00178a003 · Cited by 450
Specific Binding of [3H]Lysine-Vasopressin to Pig Kidney Plasma Membranes
Bockaert, J., Roy, C., Rajerison, R., & Jard, S. (1973) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)43489-3 · Cited by 207
Discovery, development, and some uses of vasopressin and oxytocin antagonists.
Manning, M., & Sawyer, W. H. (1989) · PubMed · Cited by 150
Acquisition of a beta-adrenergic response by adult rat hepatocytes during primary culture.
Nakamura, T., Tomomura, A., Noda, C., Shimoji, M., & Ichihara, A. (1983) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)44664-3 · Cited by 117
Vasopressin Analogs That Antagonize Antidiuretic Responses by Rats to the Antidiuretic Hormone
Sawyer, W. H., Pang, P. K. T., SETO, J., McEnroe, M., Lammek, B., & Manning, M. (1981) · Science · doi:10.1126/science.7209515 · Cited by 115
Manning, M., Lowbridge, J., Stier, C. T., Haldar, J., & Sawyer, W. H. (1977) · Journal of Medicinal Chemistry · doi:10.1021/jm00219a026 · Cited by 53
Cited by
Impact of high-throughput screening in biomedical research
Macarron, R., Banks, M. N., Bojanic, D., Burns, D. J., Cirovic, D. A., Garyantes, T., Green, D. V. S., Hertzberg, R. P., Janzen, W. P., Paslay, J. W., et al. (2011) · Nature Reviews Drug Discovery · doi:10.1038/nrd3368 · Cited by 1,364
Peptidomimetics for Receptor Ligands—Discovery, Development, and Medical Perspectives
Giannis, A., & Kolter, T. (1993) · Angewandte Chemie International Edition in English · doi:10.1002/anie.199312441 · Cited by 784
Oxytocin and Vasopressin Agonists and Antagonists as Research Tools and Potential Therapeutics
Manning, M., Misicka, A., Olma, A., Bankowski, K., Stoev, S., Chini, B., Durroux, T., Mouillac, B., Corbani, M., & Guillon, G. (2012) · Journal of Neuroendocrinology · doi:10.1111/j.1365-2826.2012.02303.x · Cited by 423
Non-peptide arginine-vasopressin antagonists: the vaptans
Decaux, G., Soupart, A., & Vassart, G. (2008) · The Lancet · doi:10.1016/s0140-6736(08)60695-9 · Cited by 376
Yamamura, Y., Ogawa, H., Yamashita, H., Chihara, T., Miyamoto, H., Nakamura, S., Onogawa, T., Yamashita, T., Hosokawa, T., Mori, T., et al. (1992) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1992.tb09058.x · Cited by 345
Self-citationYamamura, Y., Nakamura, S., Itoh, S., Hirano, T., Onogawa, T., Yamashita, T., Yamada, Y., Tsujimae, K., Aoyama, M., Kotosai, K., et al. (1998) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)37873-5 · Cited by 337
Self-citationHyponatremia in cirrhosis: From pathogenesis to treatment†
Ginés, P., Berl, T., Bernardi, M., Bichet, D. G., Hamon, G., Jiménez, W., Liard, J.-F., Martin, P.-Y., & Schrier, R. W. (1998) · Hepatology · doi:10.1002/hep.510280337 · Cited by 299
MANNING, M., STOEV, S., CHINI, B., DURROUX, T., MOUILLAC, B., & GUILLON, G. (2008) · Progress in Brain Research · doi:10.1016/s0079-6123(08)00437-8 · Cited by 296
Arroyo, V., & Colmenero, J. (2003) · Journal of Hepatology · doi:10.1016/s0168-8278(03)00007-2 · Cited by 279
Serradeil-Le Gal, C., Wagnon, J., Garcia, C., Lacour, C., Guiraudou, P., Christophe, B., Villanova, G., Nisato, D., Maffrand, J. P., & Le Fur, G. (1993) · Journal of Clinical Investigation · doi:10.1172/jci116554 · Cited by 270
An intrinsic vasopressin system in the olfactory bulb is involved in social recognition
Tobin, V. A., Hashimoto, H., Wacker, D. W., Takayanagi, Y., Langnaese, K., Caquineau, C., Noack, J., Landgraf, R., Onaka, T., Leng, G., et al. (2010) · Nature · doi:10.1038/nature08826 · Cited by 213
The Basic and Clinical Pharmacology of Nonpeptide Vasopressin Receptor Antagonists
Thibonnier, M., Coles, P., Thibonnier, A., & Shoham, M. (2001) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.41.1.175 · Cited by 146
Oshikawa, S., Tanoue, A., Koshimizu, T.-A., Kitagawa, Y., & Tsujimoto, G. (2004) · Molecular Pharmacology · doi:10.1124/mol.65.3.623 · Cited by 105
“Nonpeptide V1a receptorselective antagonists such as OPC21268 and SR49059 have been developed for potential therapeutic use in treating hypertension and congestive heart failure (Yamamura et al., 1991; Serradeil-Le Gal et al., 1993).”
BackgroundNeuropeptides in learning and memory processes
de Wied, D. (1997) · Behavioural Brain Research · doi:10.1016/s0166-4328(97)86050-0 · Cited by 63
Chan, W. Y., Wo, N. C., Stoev, S., Cheng, L. L., & Manning, M. (2000) · Experimental Physiology · doi:10.1111/j.1469-445x.2000.tb00003.x · Cited by 41
Thibonnier, M., Coles, P., Conarty, D. M., Plesnicher, C. L., & Shoham, M. (2000) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)39056-1 · Cited by 35
Metadata
- Authors
- Yamamura, Y., Ogawa, H., Chihara, T., Kondo, K., Onogawa, T., Nakamura, S., Mori, T., Tominaga, M., & Yabuuchi, Y.
- Venue
- Science
- Published
- 1991-04-26
- Volume
- 252
- Issue
- 5005
- Pages
- 572-574
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- OpenAlex
- W2090971571
- Cited by
- 271
- References
- 8
- FWCI
- 25.28
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.